Correction to Molecular profiling of cetuximab and bevacizumab treatment of colorectal tumours reveals perturbations in metabolic and hypoxic response pathways [Oncotarget, 6, 35, (2015), 38166-38180] DOI: 10.18632/oncotarget.6241

David W. Greening; Sze Ting Lee; Hong Ji; Richard J. Simpson; Angela Rigopoulos; Carmel Murone; Catherine Fang; Sylvia Gong; Graeme O'Keefe; Andrew M. Scott

doi:10.18632/oncotarget.9855

Correction to Molecular profiling of cetuximab and bevacizumab treatment of colorectal tumours reveals perturbations in metabolic and hypoxic response pathways [Oncotarget, 6, 35, (2015), 38166-38180] DOI: 10.18632/oncotarget.6241

David W. Greening
, Sze Ting Lee
, Hong Ji
, Richard J. Simpson
, Angela Rigopoulos
, Carmel Murone
, Catherine Fang
, Sylvia Gong
, Graeme O'Keefe
, Andrew M. Scott

Research output: Contribution to journal › Comment / Debate › Other › peer-review

Original language	English
Pages (from-to)	35497
Number of pages	1
Journal	Oncotarget
Volume	7
Issue number	23
DOIs	https://doi.org/10.18632/oncotarget.9855
Publication status	Published - 7 Jun 2016

Access to Document

10.18632/oncotarget.9855

Cite this

Greening, D. W., Lee, S. T., Ji, H., Simpson, R. J., Rigopoulos, A., Murone, C., Fang, C., Gong, S., O'Keefe, G., & Scott, A. M. (2016). Correction to Molecular profiling of cetuximab and bevacizumab treatment of colorectal tumours reveals perturbations in metabolic and hypoxic response pathways [Oncotarget, 6, 35, (2015), 38166-38180] DOI: 10.18632/oncotarget.6241. Oncotarget, 7(23), 35497. https://doi.org/10.18632/oncotarget.9855

@article{5b630b0a7b7048fca267a985ce84d20f,

title = "Correction to Molecular profiling of cetuximab and bevacizumab treatment of colorectal tumours reveals perturbations in metabolic and hypoxic response pathways [Oncotarget, 6, 35, (2015), 38166-38180] DOI: 10.18632/oncotarget.6241",

author = "Greening, \{David W.\} and Lee, \{Sze Ting\} and Hong Ji and Simpson, \{Richard J.\} and Angela Rigopoulos and Carmel Murone and Catherine Fang and Sylvia Gong and Graeme O'Keefe and Scott, \{Andrew M.\}",

year = "2016",

month = jun,

day = "7",

doi = "10.18632/oncotarget.9855",

language = "English",

volume = "7",

pages = "35497",

journal = "Oncotarget",

issn = "1949-2553",

publisher = "Impact Journals, LLC",

number = "23",

}

Greening, DW, Lee, ST, Ji, H, Simpson, RJ, Rigopoulos, A, Murone, C, Fang, C, Gong, S, O'Keefe, G & Scott, AM 2016, 'Correction to Molecular profiling of cetuximab and bevacizumab treatment of colorectal tumours reveals perturbations in metabolic and hypoxic response pathways [Oncotarget, 6, 35, (2015), 38166-38180] DOI: 10.18632/oncotarget.6241', Oncotarget, vol. 7, no. 23, pp. 35497. https://doi.org/10.18632/oncotarget.9855

Correction to Molecular profiling of cetuximab and bevacizumab treatment of colorectal tumours reveals perturbations in metabolic and hypoxic response pathways [Oncotarget, 6, 35, (2015), 38166-38180] DOI: 10.18632/oncotarget.6241. / Greening, David W.; Lee, Sze Ting; Ji, Hong et al.
In: Oncotarget, Vol. 7, No. 23, 07.06.2016, p. 35497.

Research output: Contribution to journal › Comment / Debate › Other › peer-review

TY - JOUR

T1 - Correction to Molecular profiling of cetuximab and bevacizumab treatment of colorectal tumours reveals perturbations in metabolic and hypoxic response pathways [Oncotarget, 6, 35, (2015), 38166-38180] DOI

T2 - 10.18632/oncotarget.6241

AU - Greening, David W.

AU - Lee, Sze Ting

AU - Ji, Hong

AU - Simpson, Richard J.

AU - Rigopoulos, Angela

AU - Murone, Carmel

AU - Fang, Catherine

AU - Gong, Sylvia

AU - O'Keefe, Graeme

AU - Scott, Andrew M.

PY - 2016/6/7

Y1 - 2016/6/7

UR - https://www.scopus.com/pages/publications/84973643444

U2 - 10.18632/oncotarget.9855

DO - 10.18632/oncotarget.9855

M3 - Comment / Debate

AN - SCOPUS:84973643444

SN - 1949-2553

VL - 7

SP - 35497

JO - Oncotarget

JF - Oncotarget

IS - 23

ER -

Correction to Molecular profiling of cetuximab and bevacizumab treatment of colorectal tumours reveals perturbations in metabolic and hypoxic response pathways [Oncotarget, 6, 35, (2015), 38166-38180] DOI: 10.18632/oncotarget.6241

Access to Document

Other files and links

Cite this